These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9100352)

  • 1. Nonrandom features of the human immunoglobulin variable region gene repertoire expressed in response to HIV-1.
    Zouali M
    Appl Biochem Biotechnol; 1996; 61(1-2):149-55. PubMed ID: 9100352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell superantigens in HIV-1 infection.
    Müller S; Köhler H
    Int Rev Immunol; 1997; 14(4):339-49. PubMed ID: 9186785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection.
    Juompan L; Lambin P; Zouali M
    FASEB J; 1998 Nov; 12(14):1473-80. PubMed ID: 9806756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.
    Neshat MN; Goodglick L; Lim K; Braun J
    Int Immunol; 2000 Mar; 12(3):305-12. PubMed ID: 10700465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells.
    Scamurra RW; Miller DJ; Dahl L; Abrahamsen M; Kapur V; Wahl SM; Milner EC; Janoff EN
    J Immunol; 2000 May; 164(10):5482-91. PubMed ID: 10799916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking immunoglobulin variable-gene expression in HIV infection.
    Zouali M
    Appl Biochem Biotechnol; 2000; 83(1-3):13-28; discussion 28-9, 145-53. PubMed ID: 10826946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human antibody variable region gene usage in HIV-1 infection.
    Wisnewski A; Cavacini L; Posner M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):31-8. PubMed ID: 8528730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell superantigens: potential modifiers of the normal human B cell repertoire.
    Domiati-Saad R; Lipsky PE
    Int Rev Immunol; 1997; 14(4):309-24. PubMed ID: 9186783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of the gp120 superantigen-binding site on human immunoglobulins.
    Karray S; Juompan L; Maroun RC; Isenberg D; Silverman GJ; Zouali M
    J Immunol; 1998 Dec; 161(12):6681-8. PubMed ID: 9862697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HIV infection on VH3 (D12 idiotope) B cells in vivo.
    Berberian L; Shukla J; Jefferis R; Braun J
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):641-6. PubMed ID: 8207642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 gp120: a novel viral B cell superantigen.
    Townsley-Fuchs J; Neshat MS; Margolin DH; Braun J; Goodglick L
    Int Rev Immunol; 1997; 14(4):325-38. PubMed ID: 9186784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?
    Parsons MS; Muller S; Kohler H; Grant MD; Bernard NF
    Hum Vaccin Immunother; 2013 Jul; 9(7):1532-8. PubMed ID: 23571168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin VH3 gene products: natural ligands for HIV gp120.
    Berberian L; Goodglick L; Kipps TJ; Braun J
    Science; 1993 Sep; 261(5128):1588-91. PubMed ID: 7690497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.
    Lecerf M; Scheel T; Pashov AD; Jarossay A; Ohayon D; Planchais C; Mesnage S; Berek C; Kaveri SV; Lacroix-Desmazes S; Dimitrov JD
    J Biol Chem; 2015 Feb; 290(8):5203-5213. PubMed ID: 25564611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable region light chain genes encoding human antibodies to HIV-1.
    David D; Zouali M
    Mol Immunol; 1995 Jan; 32(1):77-88. PubMed ID: 7870059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the B cell superantigen-binding site of HIV-1 gp120.
    Karray S; Zouali M
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1356-60. PubMed ID: 9037057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased mutation frequencies among immunoglobulin G variable region genes during viremic HIV-1 infection.
    Bowers E; Scamurra RW; Asrani A; Beniguel L; MaWhinney S; Keays KM; Thurn JR; Janoff EN
    PLoS One; 2014; 9(1):e81913. PubMed ID: 24409278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies.
    van der Donk EM; Schutten M; Osterhaus AD; van der Heijden RW
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1639-49. PubMed ID: 7888223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the variable regions of a chimpanzee monoclonal antibody with potent neutralizing activity against HIV-1.
    Vijh-Warrier S; Murphy E; Yokoyama I; Tilley SA
    Mol Immunol; 1995 Oct; 32(14-15):1081-92. PubMed ID: 8544858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection.
    Chan KW; Pan R; Costa M; Gorny MK; Wang S; Lu S; Kong XP
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.